Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
NeuroBo Pharmaceuticals (NRBO US)
Watchlist
2
Analysis
Health Care
•
United States
NeuroBo Pharmaceuticals Inc. operates as a clinical-stage biopharmaceutical company. The Company focuses on developing and commercializing therapies for the treatment of dyslipidemia. NeuroBo Pharmaceuticals conducts business in the United States.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
NeuroBo Pharmaceuticals
•
22 Aug 2024 02:00
•
Issuer-paid
NRBO: Data from Part 1 of Phase 1 Trial of DA-1726 in 3Q24
On August 14, 2024, NeuroBo Pharmaceuticals, Inc. (NRBO) announced financial results for the second quarter of 2024 and provided a business...
Zacks Small Cap Research
Follow
157 Views
Share
bullish
•
NeuroBo Pharmaceuticals
•
29 May 2024 00:00
•
Issuer-paid
NRBO: Preclinical Data on DA-1241 with Semaglutide to be Presented at EASL Congress 2024
On May 22, 2024, NeuroBo Pharmaceuticals, Inc. (NRBO) announced that preclinical data of DA-1241 in combination with semaglutide in mouse models...
Zacks Small Cap Research
Follow
210 Views
Share
1
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.34.5
x